In the 20th century, three influenza pandemics killed approximately 100 million people. The traditional method of influenza vaccine manufacturing is based on using chicken eggs. However, the necessity of the availability of millions of fertile eggs in the event of a pandemic has led research to focus on the development of cell culture-derived vaccines, which offer shorter lead-in times and greater flexibility of production. So far, the cell substrates being evaluated and in use include Vero, Madin–Darby canine kidney, PER.C6 and insect cells. However, Vero cells are the most widely accepted among others. This review introduces briefly the concepts of advanced cell culture-derived influenza vaccine production and highlights the advantages of these vaccines in terms of efficiency, speed and immunogenicity based on the clinical data obtained from different studies.

Montomoli, E., Khadang, B., Piccirella, S., Trombetta, C., Mennitto, E., Manini, I., et al. (2012). Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. EXPERT REVIEW OF VACCINES, 11(5), 587-594 [10.1586/erv.12.24].

Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production

Montomoli, Emanuele;Khadang, Baharak;Trombetta, Claudia;Manini, Ilaria;Stanzani, Valerio;Lapini, Giulia
2012

Abstract

In the 20th century, three influenza pandemics killed approximately 100 million people. The traditional method of influenza vaccine manufacturing is based on using chicken eggs. However, the necessity of the availability of millions of fertile eggs in the event of a pandemic has led research to focus on the development of cell culture-derived vaccines, which offer shorter lead-in times and greater flexibility of production. So far, the cell substrates being evaluated and in use include Vero, Madin–Darby canine kidney, PER.C6 and insect cells. However, Vero cells are the most widely accepted among others. This review introduces briefly the concepts of advanced cell culture-derived influenza vaccine production and highlights the advantages of these vaccines in terms of efficiency, speed and immunogenicity based on the clinical data obtained from different studies.
Montomoli, E., Khadang, B., Piccirella, S., Trombetta, C., Mennitto, E., Manini, I., et al. (2012). Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. EXPERT REVIEW OF VACCINES, 11(5), 587-594 [10.1586/erv.12.24].
File in questo prodotto:
File Dimensione Formato  
035-2012_ExpRevVacc-Montomoli.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 687.18 kB
Formato Adobe PDF
687.18 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/43087
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo